|
Century Therapeutics inc (IPSC) |
|
Century Therapeutics inc
IPSC's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Century Therapeutics Inc growth rates, revenue grew
by 434.46 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2248
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 15.85 %
Century Therapeutics Inc net loss decreased from $-33 millions, to $-31 millions in III. Quarter 2024,
• More on IPSC's Growth
|
|
Century Therapeutics Inc realized a net loss in trailing twelve months.
Century Therapeutics Inc realized cash reduction of $ -0.02 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 46.37.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.88.
• More on IPSC's Valuation
|
|
|
|
|
Century Therapeutics Inc realized net loss in trailing twelve months.
Century Therapeutics Inc realized cash outflow of $ -0.02per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 46.37.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.88.
Century Therapeutics Inc Price to Book Ratio is at 0.64 lower than Industry Avg. of 1787.7. and higher than S&P 500 Avg. of 0
• More on IPSC's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com